Enteral Nutritional Supplementation With Key Nutrients in Patients With Critical Illness and Cancer
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 229 (4) , 467-477
- https://doi.org/10.1097/00000658-199904000-00004
Abstract
To conduct a meta-analysis of 11 randomized controlled trials comparing enteral nutritional support supplemented with key nutrients versus standard enteral nutritional support to determine effects on morbidity and mortality rates and hospital stay. Recent studies have shown that malnutrition occurs in up to 30% of patients undergoing gastrointestinal surgery, resulting in an increased risk of postoperative complications and death. With the realization that key nutrients can modulate inflammatory, metabolic, and immune processes, enteral nutritional regimens (supplemented with large amounts of key nutrients) have been developed for clinical use. Eleven prospective, randomized controlled trials evaluating 1009 patients treated with combinations of key nutrients (Impact, Immun-Aid) were evaluated. Outcome measures examined were the incidences of pneumonia, infectious complications, and death, and length of hospital stay. Meta-analyses were undertaken to obtain the odds ratio and 95% confidence interval for incidences of infectious complications, pneumonia, and death, and the weighted mean difference and 95% confidence interval for length of hospital stay. The provision of nutritional support supplemented with key nutrients to patients with critical illness resulted in a decrease in infectious complications when compared with patients receiving standard nutritional support and a significant reduction in overall hospital stay. Similar results were documented in patients with gastrointestinal cancer. However, there were no differences between patient groups for either pneumonia or death. This meta-analysis has demonstrated that nutritional support supplemented with key nutrients results in a significant reduction in the risk of developing infectious complications and reduces the overall hospital stay in patients with critical illness and in patients with gastrointestinal cancer. However, there is no effect on death. These data have important implications for the management of such patients.Keywords
This publication has 40 references indexed in Scilit:
- Artificial nutrition after major abdominal surgeryCritical Care Medicine, 1998
- A Randomized Trial of Isonitrogenous Enteral Diets After Severe TraumaAnnals of Surgery, 1996
- Nutritional pharmacology and malignant disease: A therapeutic modality in patients with cancerBritish Journal of Surgery, 1996
- Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomySurgery, 1995
- Synthetic polyribonucleotides: current role and potential use in oncological practiceEuropean Journal of Surgical Oncology, 1995
- Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patientsCritical Care Medicine, 1995
- Early enteral administration of a formula (Impact Registered Trademark) supplemented with arginine, nucleotides, and fish oil in intensive care unit patientsCritical Care Medicine, 1995
- Glutamine-Supplemented Total Parenteral Nutrition Enhances T-Lymphocyte Response in Surgical Patients Undergoing Colorectal ResectionAnnals of Surgery, 1994
- Nutrition and malignant disease: Implications for surgical practiceBritish Journal of Surgery, 1992
- Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal HemorrhageNew England Journal of Medicine, 1985